Join
Live feed
·
INSIDERFilingvia Quantisnow
Arbutus Biopharma Corporation logo

Chief Medical Officer Sims Karen was granted 49,300 shares, increasing direct ownership by 46% to 155,494 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ABUS· Arbutus Biopharma Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABUS (Arbutus Biopharma Corporation) and more on Quantisnow.